Fund profile
Tickers
PILL
Fund manager
Total assets
$8.20 mm
Liabilities
$16.66 k
Net assets
$8.18 mm
Number of holdings
45.00
PILL stock data
45 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
GOLDMAN SACHS FIN GOV 465 INSTITUT | 1.93 mm | 1.93 mm principal | 23.60 | Short-term investment vehicle | Long | USA |
GOLDMAN FINL SQ TRSRY INST 506 | 1.80 mm | 1.80 mm principal | 21.96 | Short-term investment vehicle | Long | USA |
DREYFUS GOV'T CASH MGMT -INSTITUTIONAL CUSIP 262006208 DGCXX (#289) | 1.46 mm | 1.46 mm principal | 17.84 | Short-term investment vehicle | Long | USA |
LLY Lilly(Eli) & Co | 314.63 k | 568.00 shares | 3.85 | Common equity | Long | USA |
MRK Merck & Co Inc | 314.26 k | 3.06 k shares | 3.84 | Common equity | Long | USA |
JAZZ Jazz Pharmaceuticals plc | 310.94 k | 2.45 k shares | 3.80 | Common equity | Long | Ireland |
JNJ Johnson & Johnson | 308.40 k | 2.08 k shares | 3.77 | Common equity | Long | USA |
RPRX Royalty Pharma plc - Ordinary Shares | 307.23 k | 11.43 k shares | 3.76 | Common equity | Long | UK |
PFE Pfizer Inc. | 297.78 k | 9.74 k shares | 3.64 | Common equity | Long | USA |
VTRS Viatris Inc | 293.81 k | 33.01 k shares | 3.59 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 282.94 k | 5.69 k shares | 3.46 | Common equity | Long | USA |
BMY Bristol-Myers Squibb Co. | 282.69 k | 5.49 k shares | 3.46 | Common equity | Long | USA |
ZTS Zoetis Inc - Ordinary Shares | 282.29 k | 1.80 k shares | 3.45 | Common equity | Long | USA |
PRGO Perrigo Company plc | 272.20 k | 9.85 k shares | 3.33 | Common equity | Long | Ireland |
AXSM Axsome Therapeutics Inc | 257.71 k | 4.14 k shares | 3.15 | Common equity | Long | USA |
OGN Organon & Co. | 255.87 k | 17.30 k shares | 3.13 | Common equity | Long | USA |
ELAN Elanco Animal Health Inc | 253.68 k | 28.80 k shares | 3.10 | Common equity | Long | USA |
CTLT Catalent Inc. | 236.74 k | 6.88 k shares | 2.89 | Common equity | Long | USA |
AMPH Amphastar Pharmaceuticals Inc | 182.66 k | 4.04 k shares | 2.23 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals Inc | 167.11 k | 10.25 k shares | 2.04 | Common equity | Long | USA |
CBAY Cymabay Therapeutics Inc | 154.94 k | 9.46 k shares | 1.89 | Common equity | Long | USA |
PCRX Pacira BioSciences Inc | 152.91 k | 5.41 k shares | 1.87 | Common equity | Long | USA |
RVNC Revance Therapeutics Inc | 146.69 k | 18.59 k shares | 1.79 | Common equity | Long | USA |
SAVA Cassava Sciences Inc | 146.05 k | 7.25 k shares | 1.79 | Common equity | Long | USA |
PBH Prestige Consumer Healthcare Inc | 138.55 k | 2.33 k shares | 1.69 | Common equity | Long | USA |
CORT Corcept Therapeutics Inc | 103.62 k | 3.69 k shares | 1.27 | Common equity | Long | USA |
PLRX Pliant Therapeutics Inc | 92.10 k | 6.28 k shares | 1.13 | Common equity | Long | USA |
SUPN Supernus Pharmaceuticals Inc | 89.53 k | 3.75 k shares | 1.09 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings Inc | 85.03 k | 3.61 k shares | 1.04 | Common equity | Long | USA |
VTYX Ventyx Biosciences Inc | 78.73 k | 5.46 k shares | 0.96 | Common equity | Long | USA |
HROW Harrow Inc | 67.10 k | 4.68 k shares | 0.82 | Common equity | Long | USA |
INVA Innoviva Inc | 59.83 k | 4.82 k shares | 0.73 | Common equity | Long | USA |
ANIP ANI Pharmaceuticals Inc | 56.92 k | 922.00 shares | 0.70 | Common equity | Long | USA |
COLL Collegium Pharmaceutical Inc | 51.94 k | 2.39 k shares | 0.63 | Common equity | Long | USA |
ARVN Arvinas Inc | 51.57 k | 3.20 k shares | 0.63 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares | 51.56 k | 986.00 shares | 0.63 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals Inc | 42.98 k | 3.02 k shares | 0.53 | Common equity | Long | USA |
TBPH Theravance Biopharma Inc | 36.86 k | 3.91 k shares | 0.45 | Common equity | Long | Cayman Islands |
ACRS Aclaris Therapeutics Inc | 32.44 k | 6.51 k shares | 0.40 | Common equity | Long | USA |
EOLS Evolus Inc | 32.13 k | 4.23 k shares | 0.39 | Common equity | Long | USA |
OCUL Ocular Therapeutix Inc | 30.61 k | 10.74 k shares | 0.37 | Common equity | Long | USA |
PHAT Phathom Pharmaceuticals Inc | 23.35 k | 2.51 k shares | 0.29 | Common equity | Long | USA |
S&P PHARMACEUTICALS SELECT INDEX SWAP
UBS AG
|
-215.11 k | 1.00 contracts | -2.63 | Equity derivative | N/A | USA |
S&P PHARMACEUTICALS SELECT INDEX SWAP
Barclays Bank PLC
|
-1.35 mm | 1.00 contracts | -16.52 | Equity derivative | N/A | USA |
S&P PHARMACEUTICALS SELECT INDEX SWAP
Citibank National Association
|
-1.66 mm | 1.00 contracts | -20.35 | Equity derivative | N/A | USA |